Photocure ASA

Regulatory Filings • Nov 20, 2023

Photocure to present at four investor conferences in November/December 2023

Photocure to present at four investor conferences in November/December 2023

Press Release - Oslo, Norway, November 20, 2023: Photocure ASA (OSE: PHO), The

Bladder Cancer Company, announces its participation in four investor conferences

focusing on the healthcare sector in Q4 2023:

The SEB Healthcare Seminar will take place in Stockholm, November 21-23, 2023.

David Moskowitz, Photocure's Vice President Investor Relations will present a

corporate overview on November 22 at 10:40am CET.

The 35[th] Annual Piper Sandler Healthcare Conference will be held in New York

City, November 28-30, 2023. Dan Schneider, Photocure's President and CEO will

present on November 28 at 9:50am ET. A webcast of the presentation will be

available at: Photocure ASA (PHO NO) - 1644046

(webcasts.com) (https://pgi.webcasts.com/starthere.jsp?ei=1644046&tp_key=04b1c8d9

a7)

The 2023 Nordic American Healthcare Conference is scheduled to be held December

6-7 in New York City. Dan Schneider will present a corporate overview on

December 6 at 2:30pm ET.

The 14[th] Annual DNB Nordic Healthcare Conference will be held in Oslo on

December 14, 2023. Photocure's President and CEO Dan Schneider will present a

corporate overview at 3:35pm CET.

For further information, please contact:

Dan Schneider

President and CEO

Photocure ASA

Email: ds@photocure.com

Erik Dahl

CFO

Photocure ASA

Tel: +4745055000

Email: ed@photocure.com

David Moskowitz

Vice President, Investor Relations

Photocure ASA

Tel: +1 202 280 0888

Email: david.moskowitz@photocure.com

Media and IR enquiries:

Geir Bjørlo

Corporate Communications (Norway)

Tel: +47 91540000

Email: geir.bjorlo@corpcom.no

About Photocure ASA

Photocure: The Bladder Cancer Company delivers transformative solutions to

improve the lives of bladder cancer patients. Our unique technology, making

cancer cells glow bright pink, has led to better health outcomes for patients

worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo

Stock Exchange (OSE: PHO). For more information, please visit us at

www.photocure.com, www.hexvix.com, www.cysview.com